Assessment and management of ADR associated with cancer chemotherapy in a tertiary care hospital

Registration ID: IJNRD_193875

Published ID: IJNRD2305055

: http://doi.one/10.1729/Journal.34089

Kadeejath Thashrifa Shereen B , Risvana Abdul Rahiman P, Karthik MM, Shama Banu KP, Dr. Suja C

Adverse drug reaction, causality, chemotherapy, pharmacovigilance.

Aim: The objective of the study was to assess the causality, severity and preventability of ADRs detected by chemotherapeutic medications and to assess their management. Methodology: A prospective observational study was conducted for 6 months among 108 patients. Results: The study found a total of 263 ADRs, with the gastrointestinal system being the most affected organ system (28.6%).The drug Paclitaxel caused the highest number of ADRs when administered as monotherapy, while paclitaxel+carboplatin caused the highest number of ADRs when taken in combination. Causality was assessed using Naranjo’s causality assessment scale, it was found that 87.1% of the ADRs were probable, 7.6% were possible, and 5.3% were definite. The severity of ADRs was assessed using the Hartwig & Siegal scale, and the study found that 49.8% of ADRs were moderate level 3, 34.6% were moderate level 4a, 10.3% were mild level 2, 4.2% were moderate level 4b, and 1.1% were mild level 1.The preventability of the ADRs was assessed using the Modified Schumock and Thornton preventability scale, it was found that 68.4% of ADRs were not preventable, 18.6% were probably preventable, and 12.9% were definitely preventable. The study also found that the ADRs were managed by providing additional treatment without changing the drug regimen. Conclusion : ADRs are the major concern in patient safety and are responsible for a significant amount of mortality and morbidity, as well as financial burden on patients. It is essential to keep ADR in track, and early detection/ monitoring could help reduce the risk of one’s health.

Published Paper   E-Certificate

Kadeejath Thashrifa Shereen B , Risvana Abdul Rahiman P, Karthik MM, Shama Banu KP, & Dr. Suja C (May-2023). Assessment and management of ADR associated with cancer chemotherapy in a tertiary care hospital . INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT, 8(5), a422-a447. http://doi.one/10.1729/Journal.34089

Volume 8 Issue 5, May-2023

Pages : a422-a447

Paper Reg. ID: IJNRD_193875

Published Paper Id: IJNRD2305055

Downloads: 000122057

Research Area: Pharmacy

Author Type: Indian Author

Country: Kasaragod, Kerala, India

Published Paper PDF: https://ijnrd.org/papers/IJNRD2305055.pdf

Published Paper URL: https://ijnrd.org/viewpaperforall?paper=IJNRD2305055

Crossref DOI: http://doi.one/10.1729/Journal.34089

Journal Name: INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT(IJNRD)

UGC CARE JOURNAL PUBLICATION | ISSN: 2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar | ESTD YEAR: 2016

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Publisher: IJNRD (IJ Publication) Janvi Wave | IJNRD.ORG | IJNRD.COM | IJPUB.ORG

© 2025 — Authors hold the copyright of this article. This work is licensed under a Creative Commons Attribution 4.0 International License. and The Open Definition.

You are free to share, adapt, and redistribute the material, provided proper credit is given to the original author. 🛡️ Disclaimer: The content, data, and findings in this article are based on the authors’ research and have been peer-reviewed for academic purposes only. Readers are advised to verify all information before practical or commercial use. The journal and its editorial board are not liable for any errors, losses, or consequences arising from its use.

Call For Paper - Volume 10 | Issue 11 | November 2025

IJNRD is a Scholarly Open Access, Peer-Reviewed, Refereed, and UGC CARE Journal Publication with a High Impact Factor of 8.76 (calculated by Google Scholar & Semantic Scholar | AI-Powered Research Tool). It is a Multidisciplinary, Monthly, Low-Cost, and Transparent Peer Review Journal Publication that adheres to the UGC CARE 2025 Peer-Reviewed Journal Policy and aligns with Scopus Journal Publication standards to ensure the highest level of research quality and credibility.

IJNRD offers comprehensive Journal Publication Services including indexing in all major databases and metadata repositories, Digital Object Identifier (Crossref DOI) assignment for each published article with additional fees, citation generation tools, and full Open Access visibility to enhance global research reach and citation impact.

The INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT (IJNRD) aims to advance applied, theoretical, and experimental research across diverse academic and professional fields. The journal promotes global knowledge exchange among researchers, developers, academicians, engineers, and practitioners, serving as a trusted platform for innovative, peer-reviewed journal publication and scientific collaboration.

Indexing Coverage: Google Scholar, SSRN, ResearcherID-Publons, Semantic Scholar (AI-Powered Research Tool), Microsoft Academic, Academia.edu, arXiv.org, ResearchGate, CiteSeerX, ResearcherID (Thomson Reuters), Mendeley, DocStoc, ISSUU, Scribd, and many other recognized academic repositories.

How to submit the paper?

By Our website

Click Here to Submit Paper Online

By Mail

Send your paper to editor@ijnrd.org

You can now publish your research in IJNRD. IJNRD is a Transparent Peer-Reviewed Open Access Journal Publication (Refereed Journal), aligning with New UGC and UGC CARE recommendations.

For more details, refer to the official notice: UGC Public Notice

Submit Paper Online

Important Dates for Current issue

Paper Submission Open For: November 2025

Current Issue: Volume 10 | Issue 11 | November 2025

Impact Factor: 8.76

Last Date for Paper Submission: Till 30-Nov-2025

Notification of Review Result: Within 1-2 Days after Submitting paper.

Publication of Paper: Within 01-02 Days after Submititng documents.

Frequency: Monthly (12 issue Annually).

Journal Type: IJNRD is an International Peer-reviewed, Refereed, and Open Access Journal with Transparent Peer Review as per the new UGC CARE 2025 guidelines, offering low-cost multidisciplinary publication with Crossref DOI and global indexing.

Subject Category: Research Area

Call for Paper: More Details

Approval, Licenses and Indexing: More Details